Emmanuel Ligner serves as Director, President, and Chief Executive Officer of Avantor, Inc., a leading global provider of mission-critical products and services to the life sciences and advanced technologies industries. With over 25 years of experience in the healthcare and life sciences sectors, Ligner joined Avantor in 2021 as Executive Vice President and Head of VWR, the company's flagship brand for laboratory products and services. Prior to Avantor, he held senior leadership positions at Merck KGaA, including President of Life Science Services and Solutions, where he drove significant revenue growth and expanded the company's global footprint in bioprocessing and laboratory services. Earlier in his career, Ligner worked at GE Healthcare, honing his expertise in diagnostics and imaging technologies. Under Ligner's leadership as CEO since May 2024, Avantor has accelerated its strategic initiatives, including enhancing digital capabilities, expanding sustainable manufacturing practices, and strengthening partnerships in biopharma and advanced materials. His tenure has marked notable achievements, such as achieving double-digit organic growth in key segments and advancing innovation in high-throughput screening and gene therapy solutions. Ligner's focus on operational excellence and customer-centric innovation has positioned Avantor as a resilient leader amid evolving market dynamics. As CEO, Ligner oversees a global workforce of approximately 12,500 employees across more than 25 countries, steering the company's vision to empower scientific breakthroughs and improve human health. His strategic oversight emphasizes ESG commitments, supply chain resilience, and R&D investments, ensuring Avantor's continued dominance in serving over 300,000 customer locations worldwide.